医薬品中間体の世界市場レポート 2025年

医薬品中間体市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.4％で470億1,000万米ドルに成長します。予測期間の成長は、バイオ医薬品の革新、精密医療の開発、グリーンケミストリーへの取り組み、カスタマイズされた中間体、医薬品アウトソーシングの動向に起因すると考えられます。予測期間における主な動向には、連続フロー化学、自動化・ロボット化の進展、ナノテクノロジーの応用、生物触媒・酵素工学、戦略的サプライチェーン管理などがあります。

予測される慢性疾患の増加は、当面の医薬品中間体市場の成長を牽引するものと思われます。高齢化、ライフスタイルの変化、急速な都市化、不十分な予防対策などの要因により、3カ月以上持続し、時間の経過とともに悪化する可能性があることを特徴とする慢性疾患は増加傾向にあります。2022年3月、国立医薬品食品衛生研究所は、慢性腎臓病が人口の13.4%に影響を及ぼし、末期腎臓病（ESKD）のために腎代替療法を必要とする人が推定490万2,000人から708万3,000人になると報告しました。医薬品中間体は、慢性疾患の管理に使用される医薬品の開発に重要な役割を果たしており、このような疾患の有病率の上昇を緩和し、結果として医薬品中間体市場の成長を牽引しています。

医薬品製造の増加が予想され、医薬品中間体市場の成長を牽引すると期待されています。医薬品の生産には、医薬品物質、医薬品、または薬剤の製造プロセスが含まれます。これらの医薬品は、複数の合成工程を経る複雑な分子です。医薬品中間体は、製造プロセスの中間段階で生成される化合物であり、特に、より複雑で標的を絞った医薬品が開発されています。例えば、2023年11月、ベルギーに本部を置く欧州の製薬業界を代表する業界団体である欧州製薬団体連合会（EFPIA）は、欧州における医薬品生産総額は2023年に3,900億ユーロ（4,228億300万米ドル）に達し、2022年の3,633億ユーロ（3,938億5,700万米ドル）から増加したと報告しました。その結果、医薬品生産の増加が医薬品中間体市場の成長を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の医薬品中間体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の医薬品中間体市場：成長率分析
• 世界の医薬品中間体市場の実績：規模と成長, 2019-2024
• 世界の医薬品中間体市場の予測：規模と成長, 2024-2029, 2034F
• 世界の医薬品中間体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品中間体市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学中間体
• バルク医薬品中間体
• その他の製品
• 世界の医薬品中間体市場：カテゴリ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブランド医薬品中間体
• ジェネリック医薬品中間体
• 世界の医薬品中間体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 抗感染薬
• 心臓血管薬
• 経口糖尿病治療薬
• 抗菌薬
• その他の用途
• 世界の医薬品中間体市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオテクノロジーおよび製薬企業
• 研究機関
• その他のエンドユーザー
• 世界の医薬品中間体市場、タイプ別サブセグメンテーション：化学中間体、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品有効成分（API）
• 特殊化学品
• 世界の医薬品中間体市場、タイプ別サブセグメンテーション：バルク医薬品中間体、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前駆体化学物質
• 中間体薬物
• 世界の医薬品中間体市場、タイプ別サブセグメンテーション：その他の製品、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品中間体
• 賦形剤
• 医薬品添加物

第7章 地域別・国別分析

• 世界の医薬品中間体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品中間体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品中間体市場：競合情勢
• 医薬品中間体市場：企業プロファイル
  • BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • Meck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Dishman Carbogen Amcis Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Evonik Industries AG
• Arkema Inc.
• Lonza Group AG
• Wuxi AppTec co. Ltd
• Aurobindo Pharma Lmited.
• Lianhe Chemical Technology Co. Ltd.
• Cambrex Corporation
• Vertellus Holdings LLC.
• Hovione LLC
• Hikal Ltd.
• Codexis Inc.
• Aceto Corporation
• Interchem Corporation
• Midas Pharma GmbH
• Arbiom

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品中間体市場2029：新たな機会を提供する国
• 医薬品中間体市場2029：新たな機会を提供するセグメント
• 医薬品中間体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical intermediates are chemical compounds or substances used in the synthesis and production of active pharmaceutical ingredients (APIs) or drug substances. These intermediates play a crucial role in the development and production of a wide range of drugs and therapeutic products, and they are utilized by pharmaceutical companies and research institutions.

The main types of pharmaceutical intermediates products include chemical intermediates, bulk drug intermediates, and other products. Chemical intermediates are compounds or substances produced during the manufacturing process of chemicals and find applications in various industries, including pharmaceuticals, agrochemicals, polymers, and specialty chemicals. Categories of pharmaceutical intermediates include branded drug intermediates and generic drug intermediates. The applications of pharmaceutical intermediates cover various drugs such as analgesics, anti-infective drugs, cardiovascular drugs, oral antidiabetic drugs, antimicrobial drugs, and others. The end-users of pharmaceutical intermediates include biotech and pharma companies, research institutions, and others.

The pharmaceutical intermediates market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical intermediates market statistics, including pharmaceutical intermediates industry global market size, regional shares, competitors with a pharmaceutical intermediates market share, detailed pharmaceutical intermediates market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical intermediates industry. This pharmaceutical intermediate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical intermediates market size has grown strongly in recent years. It will grow from $33.37 billion in 2024 to $35.35 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to chemical synthesis advancements, drug development evolution, market demand and growth, research and development, regulatory compliance

The pharmaceutical intermediates market size is expected to see strong growth in the next few years. It will grow to $47.01 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to biopharmaceutical innovation, precision medicine development, green chemistry initiatives, customized intermediates, pharmaceutical outsourcing trends. Major trends in the forecast period include continuous flow chemistry, increased automation and robotics, application of nanotechnology, biocatalysis and enzyme engineering, and strategic supply chain management.

The anticipated increase in the prevalence of chronic diseases is poised to drive the growth of the pharmaceutical intermediates market in the foreseeable future. Chronic diseases, characterized by lasting three months or longer and having the potential to worsen over time, are on the rise due to factors such as an aging population, lifestyle changes, rapid urbanization, and insufficient preventive measures. In March 2022, the National Institute of Health reported that chronic kidney disorders are expected to affect 13.4% of the population, with an estimated 4.902 to 7.083 million individuals requiring renal replacement therapy for end-stage kidney disease (ESKD). Pharmaceutical intermediates play a vital role in developing medications used to manage chronic diseases, mitigating the escalating prevalence of such conditions and consequently driving the pharmaceutical intermediates market's growth.

The anticipated increase in pharmaceutical drug production is expected to drive the growth of the pharmaceutical intermediates market moving forward. Drug production involves the manufacturing process of pharmaceutical substances, medications, or drugs. These pharmaceutical drugs are complex molecules that undergo multiple synthesis steps. Pharmaceutical intermediates are the chemical compounds generated during these intermediate stages of the manufacturing process, particularly as more complex and targeted drugs are developed. For example, in November 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, reported that total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the rise in pharmaceutical drug production is fueling the growth of the pharmaceutical intermediates market.

Leading companies in the pharmaceutical intermediates market are introducing new product lines, such as API Intermediates, to enhance their market position and profitability. API intermediates, which are chemical compounds used in the synthesis of active pharmaceutical ingredients (APIs), play a crucial role in producing medications for various therapeutic areas. In October 2023, Huateng Pharmaceutical Co. Ltd., a China-based pharmaceutical company, launched its Gastrointestinal API Intermediates product line. These intermediates serve as building blocks for pharmaceutical active ingredients used in medications treating gastrointestinal system disorders, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

Leading companies in the pharmaceutical intermediates market are concentrating on developing intermediates specifically for small-molecule drugs. These intermediates are essential in the synthesis of small-molecule drugs, acting as transitional products formed during various stages of the chemical manufacturing process before culminating in the final active pharmaceutical ingredient (API) or drug substance. For example, in March 2022, Sumitomo Chemical Co. Ltd., a Japan-based chemical firm, launched active pharmaceutical ingredients (APIs) and intermediates tailored for small-molecule drugs. This initiative aims to enhance the company's capacity to meet the increasing demand for small-molecule medications by offering a broader array of high-quality APIs and intermediates.

In March 2024, International Chemical Investors Group (ICIG), a Luxembourg-based chemical company, acquired Vasant Chemicals for an undisclosed sum. This acquisition is designed to strengthen WeylChem's foothold in the global specialty chemicals market. The strategic partnership aims to provide added value for customers and stakeholders by merging the technologies and resources of both companies, thus advancing Vasant Chemicals' global expansion efforts. Vasant Chemicals is an India-based producer of pharmaceutical intermediates.

Major companies operating in the pharmaceutical intermediates market include BASF SE, Sanofi SA, Thermo Fisher Scientific Inc, Meck KGaA, Dishman Carbogen Amcis Ltd, Evonik Industries AG, Arkema Inc., Lonza Group AG, Wuxi AppTec co. Ltd, Aurobindo Pharma Lmited., Lianhe Chemical Technology Co. Ltd., Cambrex Corporation, Vertellus Holdings LLC., Hovione LLC, Hikal Ltd., Codexis Inc., Aceto Corporation, Interchem Corporation, Midas Pharma GmbH, Arbiom, Dextra Laboratories Ltd., A. R. Life Sciences, Ingenza Ltd, Chiracon GmbH, Dyadic International Inc., Elam Pharma Pvt Ltd, Yin-sheng Bio-tech Co. Ltd., Green Vision Life Sciences, Sibylla Biotech s.r.l., Pfizer CentreOne

North America was the largest region in the pharmaceutical intermediates market in 2024. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical intermediates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical intermediates market consists of sales of intermediates for API synthesis, API precursors, fine chemicals, and specialty chemicals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Intermediates Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical intermediates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical intermediates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products
• 2) By Category: Branded Drug Intermediate, Generic Drug Intermediate
• 3) By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
• 4) By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users
• Subsegments:
• 1) By Chemical Intermediate: Active Pharmaceutical Ingredients (APIs); Specialty Chemicals
• 2) By Bulk Drug Intermediate: Precursor Chemicals; Intermediate Drug Substances
• 3) By Other Products: Biopharmaceutical Intermediates: Excipients; Pharmaceutical Additives
• Companies Mentioned: BASF SE; Sanofi SA; Thermo Fisher Scientific Inc; Meck KGaA; Dishman Carbogen Amcis Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Intermediates Market Characteristics

3. Pharmaceutical Intermediates Market Trends And Strategies

4. Pharmaceutical Intermediates Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pharmaceutical Intermediates Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Intermediates PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Intermediates Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Intermediates Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Intermediates Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Intermediates Total Addressable Market (TAM)

6. Pharmaceutical Intermediates Market Segmentation

• 6.1. Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Intermediate
• Bulk Drug Intermediate
• Other Products
• 6.2. Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded Drug Intermediate
• Generic Drug Intermediate
• 6.3. Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Anti-Infective Drugs
• Cardiovascular Drugs
• Oral Antidiabetic Drugs
• Antimicrobial Drugs
• Other Applications
• 6.4. Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotech And Pharma Companies
• Research Institutions
• Other End-Users
• 6.5. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Chemical Intermediate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Pharmaceutical Ingredients (APIs)
• Specialty Chemicals
• 6.6. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Bulk Drug Intermediate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Precursor Chemicals
• Intermediate Drug Substances
• 6.7. Global Pharmaceutical Intermediates Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Intermediates
• Excipients
• Pharmaceutical Additives

7. Pharmaceutical Intermediates Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Intermediates Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Intermediates Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Intermediates Market

• 8.1. Asia-Pacific Pharmaceutical Intermediates Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Intermediates Market

• 9.1. China Pharmaceutical Intermediates Market Overview
• 9.2. China Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Intermediates Market

• 10.1. India Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Intermediates Market

• 11.1. Japan Pharmaceutical Intermediates Market Overview
• 11.2. Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Intermediates Market

• 12.1. Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Intermediates Market

• 13.1. Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Intermediates Market

• 14.1. South Korea Pharmaceutical Intermediates Market Overview
• 14.2. South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Intermediates Market

• 15.1. Western Europe Pharmaceutical Intermediates Market Overview
• 15.2. Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Intermediates Market

• 16.1. UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Intermediates Market

• 17.1. Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Intermediates Market

• 18.1. France Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Intermediates Market

• 19.1. Italy Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Intermediates Market

• 20.1. Spain Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Intermediates Market

• 21.1. Eastern Europe Pharmaceutical Intermediates Market Overview
• 21.2. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Intermediates Market

• 22.1. Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Intermediates Market

• 23.1. North America Pharmaceutical Intermediates Market Overview
• 23.2. North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Intermediates Market

• 24.1. USA Pharmaceutical Intermediates Market Overview
• 24.2. USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Intermediates Market

• 25.1. Canada Pharmaceutical Intermediates Market Overview
• 25.2. Canada Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Intermediates Market

• 26.1. South America Pharmaceutical Intermediates Market Overview
• 26.2. South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Intermediates Market

• 27.1. Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Intermediates Market

• 28.1. Middle East Pharmaceutical Intermediates Market Overview
• 28.2. Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Intermediates Market

• 29.1. Africa Pharmaceutical Intermediates Market Overview
• 29.2. Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Intermediates Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Intermediates Market Competitive Landscape
• 30.2. Pharmaceutical Intermediates Market Company Profiles
  • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Meck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Dishman Carbogen Amcis Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Intermediates Market Other Major And Innovative Companies

• 31.1. Evonik Industries AG
• 31.2. Arkema Inc.
• 31.3. Lonza Group AG
• 31.4. Wuxi AppTec co. Ltd
• 31.5. Aurobindo Pharma Lmited.
• 31.6. Lianhe Chemical Technology Co. Ltd.
• 31.7. Cambrex Corporation
• 31.8. Vertellus Holdings LLC.
• 31.9. Hovione LLC
• 31.10. Hikal Ltd.
• 31.11. Codexis Inc.
• 31.12. Aceto Corporation
• 31.13. Interchem Corporation
• 31.14. Midas Pharma GmbH
• 31.15. Arbiom

32. Global Pharmaceutical Intermediates Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Intermediates Market

34. Recent Developments In The Pharmaceutical Intermediates Market

35. Pharmaceutical Intermediates Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Intermediates Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Intermediates Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Intermediates Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer